1. Introduction {#sec1}
===============

Glutamate and glutamine are highly abundant amino acids found in most foodstuffs and, in total, comprise somewhere between 5 and 15% of dietary protein ([@bib10], [@bib11]). Similarly, these two amino acids comprise a large proportion of the body pool of amino acids, both in the free form and incorporated into protein. Traditionally glutamate and glutamine have been considered to be non-essential (dispensable) and, due to the almost complete catabolism of dietary glutamate and glutamine in the intestine, essentially all of the large body pool is synthesized endogenously ([@bib3]). The definition of what is, and what is not, an essential amino acid however, is not unequivocal. [@bib19], [@bib20] defined an essential amino acid as one that the body cannot make in sufficient amounts to maintain growth or nitrogen balance. This definition is noteworthy since it does not say that the body cannot make the amino acid, rather that it cannot make sufficient amounts for a key purpose. Recently there has been a reconsideration of additional functions of amino acids and some, including glutamine, are now considered as conditionally essential at key times ([@bib25], [@bib26]). In this paper the nutritional aspects of glutamate and glutamine will be described and the requirements, if any, during gestation and lactation, and for optimal growth in neonates, will be considered particularly with reference to feeding lower protein diets.

2. Glutamate and glutamine {#sec2}
==========================

2.1. Metabolism {#sec2.1}
---------------

The healthy adult human contains over 80 g of free glutamine, with \>98% of it inside skeletal muscle cells at concentrations of 20 mM and above. In addition, plasma glutamine is turning over at very high rates (60 to 80 g per day in healthy subjects) ([@bib3], [@bib24], [@bib25]). Glutamine is made via the action of glutamine synthetase from glutamate and ammonia ([Fig. 1](#fig1){ref-type="fig"}), primarily in skeletal muscle, lungs, adipose tissue and liver. Glutamine is a precursor for a number of biosynthetic pathways required for growth and cell division ([Fig. 2](#fig2){ref-type="fig"}). The bulk of glutamine however, is hydrolyzed by glutaminase [Fig. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} and ultimately serves as substrate for hepatic gluconeogenesis and urea synthesis, renal ammoniagenesis, and is the major respiratory fuel for enterocytes and cells of the immune system ([@bib3]). Glutamine is also an important signaling molecule, often acting by activation of the mammalian target of rapamycin (mTOR) ([Fig. 2](#fig2){ref-type="fig"}), stimulating anabolic functions such as protein synthesis, cell growth and differentiation, and inhibiting catabolic functions such as protein degradation and apoptosis ([@bib4]). In addition, during gestation there is a large uptake of glutamine across the placenta, together with placental glutamine synthesis, resulting in large amounts of glutamine available for fetal growth ([Fig. 3](#fig3){ref-type="fig"}). Likewise in lactation, free and protein bound glutamate and glutamine, derived from both the circulation and mammary gland synthesis ([Fig. 3](#fig3){ref-type="fig"}), are the most abundant amino acids in milk ([@bib27], [@bib5], [@bib22]). Thus the maintenance of glutamate and glutamine homeostasis is important for the well-being of a number of tissues in the body, particularly during gestation, lactation and growth.Fig. 1Glutamine synthetase and glutaminase.Fig. 2Pathways of glutamine and glutamate metabolism. The majority of glutamine is degraded to glutamate and then used as a substrate for urea and glucose synthesis or as a fuel (ATP production). Although glutamine is an essential precursor for many important compounds but these represent a small (\<3%) fraction of glutamine metabolism. Glutamine also acts as an anabolic signal, often via activation of mammalian target of rapamycin (mTOR).Fig. 3Glutamine metabolism during pregnancy and lactation. Increased dietary intake provides glutamine and glutamate for the small intestine, but skeletal muscle provides most of the circulating glutamine that is derived from other amino acids, including those from both the diet and muscle proteolysis. The size of the arrows indicates a rough estimate of the magnitude of glutamine flux.

2.2. Glutamine becomes conditionally essential in hyper-catabolic states {#sec2.2}
------------------------------------------------------------------------

In healthy animals the body is able to synthesize considerable quantities of glutamine and there is no apparent evidence of a shortage. About 30 years ago however, it became apparent that in hyper-catabolic patients glutamine requirements (for the immune system, wound healing, acid--base balance and gluconeogenesis) could increase beyond the endogenous capacity for glutamine synthesis ([@bib25]). An early response to such stress is a rapid release of muscle glutamine and a resultant drop in both muscle and plasma free glutamine concentrations. Subsequently there is an up-regulation of muscle glutamine synthesis from amino acids derived from a net increase in muscle proteolysis. In clinical studies it has been proposed that a plasma glutamine concentration \<0.42 mM (normal 0.6 to 0.8 mM) indicates glutamine insufficiently and exogenous glutamine should be provided ([@bib25]). Although beyond the scope of this text, a number of studies have shown benefits for supplemental glutamine given to such patients ([@bib23]).

2.3. Glutamine and glutamate are conditionally essential during pregnancy, lactation and growth {#sec2.3}
-----------------------------------------------------------------------------------------------

In the domestic animal industry the treatment of hyper-catabolic conditions is of little interest and thus the important question is "is glutamine conditionally essential at other times"? We observed that plasma and muscle glutamine concentrations fell steadily throughout lactation in the horse and this was accompanied by a loss of skeletal muscle, representing a mildly catabolic state ([@bib13]) as seen in a number of other species ([@bib12], [@bib2], [@bib18]). Thus the question arises if glutamate or glutamine supplementation would be beneficial during gestation and lactation. As mentioned above these conditions are associated with increased glutamine needs, for fetal growth and milk production, and it was traditionally assumed that such needs were met by catabolism of extra dietary amino acids ([Fig. 3](#fig3){ref-type="fig"}). Thus it was surprising to find that such substrates were insufficient and that additional endogenous substrates for glutamine synthesis were drawn from the mother׳s lean body mass. We proposed that supplementation with glutamine and/or glutamate may provide the extra glutamine required during lactation and thus spare the lean body mass of the mother. Similarly, it is well established that the neonatal gut is particularly sensitive to stress and that weaning, particularly abrupt early weaning, is often associated with negative growth and pathological outcomes that are clearly related to intestinal and immunologicadysfunction. Given that glutamate and glutamine are the preferred fuels of this tissue, and of cells of the immune system, ([@bib3], [@bib4]) then supplements may aid to maintain intestinal function throughout weaning.

2.4. Glutamine and glutamate supplements are beneficial during pregnancy, lactation and growth {#sec2.4}
----------------------------------------------------------------------------------------------

A number of studies over the past 10 years have shown that glutamine and/or glutamate supplementation can be beneficial to recently weaned piglets ([@bib8], [@bib9], [@bib22], [@bib28], [@bib29], [@bib30]). Such studies have indicated benefits in preventing intestinal atrophy, maintaining anti-oxidant status and lessening the incidence of diarrhea, and result in increased weight gain and improved food efficiency. One study ([@bib7]) has looked at oral glutamine supplementation to suckling piglets and reported increased weight gain and protection of the intestine from oxidative damage, particularly in piglets that were treated with bacterial endotoxin as a model of inflammatory disease. Similarly, a recent study has shown that supplementing creep feeders with glutamine and glutamate results in improvements in intestinal and immunological health, particularly at abrupt weaning ([@bib1]). In recent work ([@bib12], [@bib21]) we showed that supplemental glutamine and glutamate to the lactating sow increased the glutamine content of the milk and so delivered more glutamine to the piglets. Such an approach may offer a very attractive mechanism to increase the availability of glutamine to the piglet at this very vulnerable time. In addition, we found that glutamine, and glutamine with glutamate, supplementation also attenuated some of the loss of lean body mass in the sow during lactation.

2.5. The future of glutamine supplementation {#sec2.5}
--------------------------------------------

There is therefore extensive evidence that glutamine and glutamate supplementation may have considerable benefits both to the sow and the piglet when given orally to the sow during the transition period and to the piglet throughout the post-weaning period. Thus future questions regarding glutamine and glutamate supplementation are related to when to give it, how much to give, what outcomes are important, and what mechanisms are involved? The evidence from published trials ([@bib1], [@bib7], [@bib8], [@bib9], [@bib13], [@bib21], [@bib22], [@bib28], [@bib29], [@bib30]) using pure glutamine or a mixture of glutamine and glutamate, show beneficial effects between 0.5 and 1.5% (by weight). There is limited evidence of benefits at lower levels (0.25%) and no evidence of any increased benefits at levels above 1.0%. Grain based diets are relatively deficient in glutamine ([@bib11]) and supplementation can correct this deficiency without the need to increase total protein. Since glutamate/glutamine are not essential in the traditional sense, any future studies should focus on requirement trials using models where there is evidence that they are conditionally essential, e.g., the sow during gestation and lactation, and the neonatal piglet. However, it is also important to decide on the outcomes that will be used to set the requirement. Will this be weight gain, feed intake, or more mechanistic variables such as intestinal morphology and biochemistry, or even include detailed examination of muscle growth and quality? To date such variables have received very little attention and neither the mechanisms involved nor the physiological significance have been adequately addressed.

3. Conclusions {#sec3}
==============

In the original work of [@bib19], [@bib20]), that defined our classification of dietary amino acids into essential and non-essential, it was noted that animals fed a mixture of essential amino acids did not grow as well as animals fed these amino acids plus an additional source of nitrogen. Such early studies clearly illustrate that a certain amount of dietary non-essential amino acids are required and that glutamate may be the ideal source ([@bib6]). A number of studies were carried out that claimed dietary glutamate could be essential for growth in chickens ([@bib15], [@bib14]), and it has been proposed that glutamine is limiting for milk production in the cow ([@bib17], [@bib16]), but overall, the use of dietary glutamate/glutamine has received very little attention over the past 50 years. But, despite having been classified as non-essential, there is increasing evidence that supplemental glutamate/glutamine may be beneficial, not only in hypercatabolic states, but also in the maintenance of optimal health and maximal rates of growth in healthy animals. Currently a number of important questions relating to physiological condition, species under study and the form and amount of the supplements, remain to be addressed before the full benefits to domestic animal production can be realized.

Conflict of interest {#sec4}
====================

The author has received research funding from Ajinomoto do Brasil.

Work done in the author׳s laboratory was supported, in part, by the New Jersey Agricultural Experiment Station, the New Jersey Institute of Food, Nutrition and Health, and Ajinomoto do Brasil.

Peer review under responsibility of Chinese Association of Animal Science and Veterinary Medicine.
